Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
953.2 INR | +0.21% | +3.42% | +38.38% |
Apr. 24 | Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection | MT |
Apr. 23 | China Medical System's Anti-Anaemia NDA Accepted in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.38% | 11.49B | |
+20.44% | 21.89B | |
+13.49% | 14.45B | |
+13.52% | 13.63B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.06B | |
-5.36% | 4.66B | |
+2.40% | 4.53B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences' Consolidated Net Profit Slips in Fiscal Q1; Revenue Misses Estimates